Andrew Singer Net Worth & Insider Trades

Andrew Singer - EVP & CFO, Epizyme, Inc

As of August 10, 2017

What is Andrew Singer's Net Worth?

The current estimated net worth of Epizyme, Inc's EVP & CFO, Andrew Singer, is estimated to be about $346.95K . Andrew Singer owns about 40,529 units of Epizyme, Inc common stock. In the last 2 years at Epizyme, Inc, Andrew Singer has sold an estimated value of $325.44K worth.

What is Andrew Singer's Past Insider Trading?

Andrew Singer's largest sale order was 12,158 units , worth over $115.99K on February 10, 2016. In total, Andrew Singer has made about 23 transactions over 2 years of their time at Epizyme, Inc. Andrew Singer usually trades in July, May, February and April, with the busiest year in 2016. The most recent transaction was a sale order of 3,024 units , worth over $46.87K on July 5, 2017.

Andrew Singer

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Andrew Singer's' Mailing Address?

  • Mailing address is C/o Epizyme, Inc. 400 Technology Square, 4th Floor Cambridge MA 02139 MA

Epizyme, Inc Executive Compensation

Name
Year
Salary
Bonus
Restricted Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Robert B. Bazemore Jr. 2020 $650,000 - $3,237,620 $4,103,853 $370,500 $96,369 $8,458,342
Robert B. Bazemore Jr. 2019 $592,937 - $1,105,393 $2,060,531 $409,127 $5,630 $4,173,618
Robert B. Bazemore Jr. 2018 $575,667 - - $2,748,939 $320,575 $5,690 $3,650,871
Paolo Tombesi 2020 $460,000 - $250,006 $750,730 $174,800 $48,198 $1,683,734
Paolo Tombesi 2019 $168,901 - $612,848 $1,173,669 $76,076 $146,971 $2,178,465
Matthew E. Ros 2020 $447,982 - $250,006 $750,730 $174,800 $11,271 $1,634,789
Matthew E. Ros 2019 $432,600 - $538,793 $899,137 $199,861 $11,598 $2,081,989
Matthew E. Ros 2018 $420,000 - - $1,099,576 $187,100 $12,214 $1,718,890
Dr. Shefali Agarwal 2020 $478,000 - $274,990 $825,799 $199,804 $7,154 $1,785,747
Dr. Shefali Agarwal 2019 $463,500 - $894,607 $1,255,325 $265,122 $8,652 $2,887,206
Dr. Shefali Agarwal 2018 $199,615 $125,000 - $1,472,846 $200,500 $1,648 $1,999,609
Jeffery L. Kutok, M.D., Ph.D. 2020 $337,500 $85,000 $374,996 $1,124,996 $134,663 $6,813 $2,063,968
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1571498/000119312521138283/d839557ddef14a.htm

What are Epizyme, Inc's Past Insider Trades?

Epizyme, Inc's most recent insider trade came on April 13, 2022 by Jeffery Kutok who sold 2,741 units worth $2.47K . In the last 9 years, insiders at Epizyme, Inc have sold an estimated value of $156.28M and bought an estimated value of $381.12M worth of shares. Insider trading is most common in June, with the busiest year in 2014. The most active traders at the company are David Mott, Director,  Robert Copeland, President Research and CSO,  and Andrew Singer, EVP & CFO .

Epizyme, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1